Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

27 Oct 2026 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Valganciclovir for Oral Solution, 50 mg/mL. A press release being issued in this regard is enclosed.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..